Home > Insider Trading > Filing (0001576280-25-000141)

Filing Details

Accession Number:: 0001576280-25-000141
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-05 21:02:01
Reporting Period:: 2025-05-01

Filing Date:: 2025-05-05
Accepted Time:: 2025-05-05 21:02:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576280	Guardant Health Inc.	GH	Services-Medical Laboratories (8071)	454139254

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753159	Amirali Talasaz	3100 Hanover Street Palo Alto CA 94304	Co-Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2025-05-01	18,069	$47.67	2,291,387	No	4	S	Direct
Common Stock	Disposition	2025-05-01	38,477	$48.71	2,252,910	No	4	S	Direct
Common Stock	Disposition	2025-05-01	44,691	$49.53	2,208,219	No	4	S	Direct
Common Stock	Disposition	2025-05-01	3,445	$50.91	2,204,774	No	4	S	Direct
Common Stock	Disposition	2025-05-01	1,748	$51.56	2,203,026	No	4	S	Direct
Common Stock	Disposition	2025-05-01	354	$52.57	2,202,672	No	4	S	Direct
Common Stock	Disposition	2025-05-02	13,932	$50.47	2,188,740	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2024.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.18 to $48.175 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.185 to $49.16 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.19 to $50.06 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.405 to $51.34 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.43 to $51.76 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.46 to $52.75 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.84 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.